Reuters logo
BRIEF-Cadila Healthcare says Zydus gets final nod from USFDA for doxycycline hyclate tablets
October 31, 2017 / 8:24 AM / 18 days ago

BRIEF-Cadila Healthcare says Zydus gets final nod from USFDA for doxycycline hyclate tablets

Oct 31 (Reuters) - Cadila Healthcare Ltd

* Says ‍zydus receives final approval from USFDA for doxycycline hyclate tablets USP

* Says drug to be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad‍​​ Source text - bit.ly/2z0ssZH Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below